| abstract |
The present invention includes atherosclerosis through the co-administration of a therapeutically effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof, and rosuvastatin or pravastatin, or a pharmaceutically acceptable salt of rosuvastatin or pitavastatin. And methods of treating and / or preventing cardiovascular, cholesterol, and lipid-related disorders. The present invention further provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of a composition comprising pitavastatin, or a pharmaceutically acceptable salt of rosuvastatin or pitavastatin, to provide. |